|
LY6G5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.37029999966754E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.25949999996156E-06 |
| Normal-vs-Stage2 |
4.277600E-02 |
| Normal-vs-Stage3 |
3.820400E-01 |
| Normal-vs-Stage4 |
1.774190E-01 |
| Stage1-vs-Stage2 |
8.118400E-01 |
| Stage1-vs-Stage3 |
1.556270E-03 |
| Stage1-vs-Stage4 |
7.912200E-01 |
| Stage2-vs-Stage3 |
9.932400E-02 |
| Stage2-vs-Stage4 |
7.444000E-01 |
| Stage3-vs-Stage4 |
2.992600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.61859999958658E-07 |
| Normal-vs-AfricanAmerican |
1.441090E-04 |
| Normal-vs-Asian |
7.638800E-01 |
| Caucasian-vs-AfricanAmerican |
8.069000E-01 |
| Caucasian-vs-Asian |
9.559900E-03 |
| AfricanAmerican-vs-Asian |
7.464900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4226000044637E-08 |
| Normal-vs-Female |
3.580600E-03 |
| Male-vs-Female |
9.447900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.277500E-03 |
| Normal-vs-Extreme_Weight |
5.84459999999343E-05 |
| Normal-vs-Obese |
4.236100E-04 |
| Normal-vs-Extreme_Obese |
8.795800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.932600E-01 |
| Normal_Weight-vs-Obese |
8.123400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.039000E-01 |
| Extreme_Weight-vs-Obese |
7.579000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.036400E-01 |
| Obese-vs-Extreme_Obese |
1.976960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.671500E-02 |
| Normal-vs-Age(41-60Yrs) |
9.78299999898624E-08 |
| Normal-vs-Age(61-80Yrs) |
1.94027000000041E-05 |
| Normal-vs-Age(81-100Yrs) |
3.388000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.910600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.631400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.491200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.232000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.402190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.300600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.85786974482971E-12 |
| Normal-VS-Type2 PRCC |
9.273000E-01 |
| Normal-VS-KIRP CIMP |
6.990800E-01 |
| Normal-VS-Unclassified PRCC |
2.806400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.73137068518281E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.607820E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.702490E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.119800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.316000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.366220E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.355500E-02 |
| Normal-vs-N1 |
7.123500E-02 |
| Normal-vs-N2 |
4.101000E-01 |
| N0-vs-N1 |
9.905200E-01 |
| N0-vs-N2 |
2.742400E-01 |
| N1-vs-N2 |
2.383200E-01 |
|
|
